(Q39136410)

9 September 2017

title

Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA. (English)

1 reference

9 September 2017

6

1 reference

9 September 2017

3

R Kordek

1 reference

9 September 2017

V Novitskaya

1

1 reference

9 September 2017

H Romanska

2

1 reference

9 September 2017

P Potemski

4

1 reference

9 September 2017

R Kusińska

5

1 reference

9 September 2017

E Odintsova

7

1 reference

9 September 2017

F Berditchevski

8

1 reference

9 September 2017

language of work or name

English

0 references

publication date

24 June 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

33

1 reference

9 September 2017

issue

21

1 reference

9 September 2017

page(s)

2779-2789

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.231

9 September 2017

exact match

0 references

cites work

ErbB receptors and signaling pathways in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Treatment of HER2-positive breast cancer: current status and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Loss of phosphatase and tensin homolog or phosphoinositol-3 kinase activation and response to trastuzumab or lapatinib in human epidermal growth factor receptor 2-overexpressing locally advanced breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Targeting integrin beta4 for cancer and anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

ErbB2 requires integrin alpha5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Beta1-integrin circumvents the antiproliferative effects of trastuzumab in human epidermal growth factor receptor-2-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Functional characterization of integrin alpha6beta4 adhesion interactions using soluble integrin constructs reveals the involvement of different functional domains in the beta4 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Integrin expression and survival in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

α3β1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Tetraspanin CD151 stimulates adhesion-dependent activation of Ras, Rac, and Cdc42 by facilitating molecular association between β1 integrins and small GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Tetraspanin CD151 maintains vascular stability by balancing the forces of cell adhesion and cytoskeletal tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

The effect of cell-ECM adhesion on signalling via the ErbB family of growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Ligand-induced ErbB receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

GxxxG motifs, phenylalanine, and cholesterol guide the self-association of transmembrane domains of ErbB2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Cholesterol dictates the freedom of EGF receptors and HER2 in the plane of the membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Evidence of a tendency to self-association of the transmembrane domain of ErbB-2 in fluid phospholipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Motility and invasion are differentially modulated by Rho family GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Quantification of integrin receptor agonism by fluorescence lifetime imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Measuring FRET using time-resolved FLIM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

Role of gangliosides in the association of ErbB2 with lipid rafts in mammary epithelial HC11 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.231

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.231

1 reference

Dimensions Publication ID

9 September 2017

1000598198

0 references

1 reference